Recombinant Acyl carrier protein (acpP)
Description
Introduction to Recombinant Acyl Carrier Protein (acpP)
Recombinant Acyl Carrier Protein (acpP) is a genetically engineered form of the native acyl carrier protein, a critical component in bacterial fatty acid synthesis (FAS). It serves as a scaffold for fatty acid chain elongation, shuttling intermediates between enzymatic domains. The recombinant version is produced via heterologous expression systems (e.g., E. coli) to enable high-purity studies of FAS mechanisms and biotechnological applications.
Primary and Secondary Structure
acpP comprises 77–80 amino acids, including a conserved serine residue for 4'-phosphopantetheine (4'-PP) prosthetic group attachment. Key structural features include:
| Feature | Description |
|---|---|
| Molecular Weight | ~8.8–9.2 kDa |
| Isoelectric Point (pI) | 4.5–5.0 |
| 4'-PP Attachment Site | Serine-36 (universal in bacterial acpP) |
| Thermal Stability | Stable up to 45°C; denatures above 60°C |
Functional Role in Fatty Acid Synthesis
acpP facilitates FAS by:
-
Transporting acyl intermediates between enzymatic modules (e.g., ketoacyl-ACP synthase, enoyl-ACP reductase).
-
Stabilizing reaction intermediates via hydrophobic interactions.
-
Undergoing post-translational modification (phosphopantetheinylation) for activity.
Recombinant Expression Systems
| Host | Yield (mg/L) | Purity (%) | Reference |
|---|---|---|---|
| E. coli BL21 | 15–20 | >95 | |
| Bacillus subtilis | 8–10 | 90 |
Key Purification Steps
-
Affinity Chromatography: His-tag or GST-tag systems for initial isolation.
-
Ion-Exchange Chromatography: Resolves isoforms caused by incomplete phosphopantetheinylation.
-
Size-Exclusion Chromatography: Ensures monomeric state for functional assays.
Key Studies on acpP Dynamics
-
Substrate Specificity: Mutagenesis at Lys-41 and Asp-35 alters acyl chain selectivity.
-
Antibiotic Targeting: acpP inhibitors (e.g., cerulenin) disrupt FAS in Staphylococcus aureus.
-
Biotechnological Engineering: Engineered acpP variants enable production of medium-chain fatty acids in E. coli (30% yield increase).
Applications in Metabolic Engineering
-
Biofuel Production: acpP overexpression increases fatty acid titer by 2.5-fold in Corynebacterium glutamicum.
-
Antimicrobial Drug Development: High-throughput screens using recombinant acpP identified novel FAS-II inhibitors.
Current Limitations
-
Solubility Issues: Acylated acpP tends to aggregate, complicating in vitro assays.
-
Post-Translational Modification: Heterogeneity in 4'-PP attachment reduces batch consistency.
Emerging Trends
-
SynBio Platforms: CRISPR-edited acpP for orthogonal FAS pathways in yeast.
-
Structural Mimetics: Peptide-based acpP analogs to bypass bacterial resistance mechanisms.
